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Men and women exhibit significant differences in obesity, cardiovascular disease and diabetes. To
provide better diagnosis and treatment for both sexes, it is important to identify factors that
underlie the observed sex differences. Traditionally, sex differences have been attributed to the
differential effects of male and female gonadal secretions (commonly referred to as “sex
hormones”), which do substantially influence many aspects of metabolism and related diseases.
Less appreciated as a contributor to sex differences are the fundamental genetic differences
between males and females, which are ultimately determined by the presence of an XX or XY sex
chromosome complement. Here we review the mechanisms by which gonadal hormones and sex
chromosome complement each contribute to lipid metabolism and associated diseases, and the
current approaches that are used to study them. We focus particularly on genetic approaches
including genome-wide association studies in humans and mice, “–omics” and “systems genetics”
approaches, and unique experimental mouse models that allow distinction between gonadal and
sex chromosome effects.
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I. Sex and metabolism
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a. Why is it important to understand sex differences in metabolism?
The most prevalent diseases in developed countries are cardiovascular disease, diabetes, and
some forms of cancer (35, 95). The incidence of these diseases increases in the presence of a
group of risk factors known as the Metabolic Syndrome (MetSyn). MetSyn is defined by the
presence of three of the following five risk factors: abdominal obesity, elevated triglyceride
levels, low high density lipoprotein (HDL) cholesterol levels, high blood pressure
(hypertension), and elevated fasting blood glucose levels (73). Sex differences exist in nearly
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all of the components of MetSyn (Figure 1). For example, females have evolved specific
mechanisms to favor adipose tissue storage, whereas mobilization of fat stores tends to be
more efficient in males (40, 60, 77, 90). Compared to men, women tend to have greater
insulin sensitivity, and the sexes differ in lipoprotein profiles (30, 85). It has become clear
that it is critical to understand sex differences in metabolism to optimize prevention,
diagnosis, and therapeutic intervention for both sexes.
Here we review sex differences in obesity, other components of the MetSyn, and related
factors such as the gut microbiome, with an emphasis on the genetic mechanisms underlying
these differences. In the sections below, we first discuss the components of sex and
approaches used to study sex effects. We then review the sex differences in obesity and other
MetSyn components in humans, and highlight studies in experimental models that shed light
on the mechanisms involved.
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b. Components of sex: gonadal hormones and sex chromosome complement
An understanding of why one sex is more susceptible to specific disease processes requires
analysis of the component parts of sex. Differences between men and women can be
influenced by sex and gender. Sex refers to the biological attributes of males and females
that result from the presence of female (XX) or male (XY) sex chromosomes, which
ultimately determine the levels and types of gonadal hormones (Figure 2). Gender refers to
characteristics that a society or culture defines as masculine or feminine. In humans in
particular, gender may influence behaviors that affect metabolism and related diseases.
However, gender effects are challenging to assess experimentally and data are lacking on
their effects on metabolism, and we will therefore limit our review to the biological
components of sex differences.

Author Manuscript
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The most widely studied sex difference between males and females has been the effect of
gonadal hormones. In human studies, the contribution of gonadal hormones to a trait of
interest is often addressed by comparing women before and after the age of menopause, with
differences between the two attributed to the reduced levels of ovarian hormones after
menopause. Studies of this sort have demonstrated that post-menopausal women have
altered body fat distribution and increased incidence of cardiovascular disease, hypertension,
diabetes and other disorders (41, 68, 74, 122). The levels of androgens also influence
metabolic disease. Testosterone levels typically diminish in men with age, and low
testosterone levels in men are associated with increased body fat and cardiovascular disease
(3, 12, 99). However, these studies are confounded by the fact that the pre- and postmenopausal (or high and low testosterone) groups usually constitute different individuals
due to the difficulty of performing longitudinal studies for several years in humans, and
comparisons between groups could therefore be influenced by genetic and environmental
heterogeneity. Studies in humans are also complicated by the fact that reductions in gonadal
hormone levels in older men and women cannot necessarily be distinguished from
independent changes associated with aging.
In addition to gonadal hormones, sex chromosome complement could contribute to sex
differences in metabolic traits (8, 69). It has been difficult to address whether hormoneindependent effects of gonadal sex occur in humans because, typically, XX chromosomes
Annu Rev Nutr. Author manuscript; available in PMC 2018 August 21.
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and ovaries occur together, and XY chromosomes and testes occur together (Figure 2). Some
studies of metabolic factors have been performed on individuals with sex chromosome
anomalies (Turner syndrome or Klinefelter syndrome), and have reported increased
adiposity and other features of MetSyn (13, 14, 19). However, it is difficult to tease apart the
role of sex chromosome complement from gonadal hormones in these individuals because
the alterations in chromosome complement occur in concert with abnormal hormones levels.
Individuals with Turner syndrome (45, XO) have low endogenous levels of ovarian
hormones such that it is impossible to distinguish the effects of the single X chromosome
from those resulting from abnormal ovarian hormone levels (44, 48). Furthermore, Turner
syndrome subjects often have congenital heart defects, which lead to heart disease
independent of MetSyn (31). Individuals with Klinefelter syndrome (47, XXY) have reduced
endogenous androgen levels and are often treated with exogenous androgens, which makes it
difficult to distinguish effects of the XXY chromosome complement from those of the
altered androgen levels (53). In addition to the factors outlined above, the interpretation of
metabolic disease traits in Turner and Klinefelter subjects has been limited by small
available cohort sizes that preclude meaningful conclusions about metabolic parameters.
c. Approaches to study sex differences

Author Manuscript

To overcome some of the limitations in studying the components of sex effects in humans,
experimental animal models are valuable; unique genetic tools in the mouse make it a
particularly useful animal model. Unlike humans, inbred mice allow an analysis of high and
low gonadal hormone levels on the identical genetic background. The action of gonadal
hormones can be classified into two temporal classes: the permanent effects of gonadal
hormones that lead to the development of sex differences during fetal and neonatal
development, and the acute actions of gonadal hormones that cause specific responses on
numerous processes throughout life. The acute effects of gonadal hormones are reversible,
and a standard way to identify acute hormone effects is to compare adult mice with intact
gonads to those from which gonads were removed in adulthood. Those sex differences that
are caused by acute hormonal effects will be abolished in gonadectomized mice, whereas
sex differences resulting from the permanent effects of gonads during development will
remain.

Author Manuscript

The origin of male and female gonads and the hormones that they produce traces back to the
presence of either XX or XY sex chromosomes (Figure 2). Furthermore, at a more
fundamental level than hormone action, simply the presence of either XX or XY
chromosomes leads to sex differences at the cellular level because of the differential action
of genes on the X and Y chromosomes (7). For example, during early embryonic growth
prior to the presence of gonads or gonadal hormones, male embryos are larger than female
embryos in mice, humans, and several other mammals (16). In the mouse, these differences
have been attributed to a combination of effects from the presence of the Y chromosome in
male embryos and the sexual imbalance between the number of X chromosomes in males vs.
females (17, 18). Following differentiation of the gonads, it is difficult to cleanly separate
effects due to hormones from those resulting from the sex chromosome complement. This
led to the generation of mouse models that allow the independent segregation of gonadal
type from sex chromosome complement.
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The most widely used model to distinguish gonadal and chromosome sex effects is known as
the Four Core Genotypes (FCG) mouse model (Figure 3). This model generates mice having
XX chromosomes on both male and female gonadal backgrounds and XY mice on male and
female gonadal backgrounds (4–6). This is accomplished by using a Y chromosome from
which the testis-determining Sry gene has been deleted. Inheritance of the Sry-deleted Y
chromosome fails to specify male gonads, and female gonads develop instead, allowing
production of XY female mice. In addition, an Sry transgene is inserted into chromosome 3,
such that it segregates independently of the sex chromosomes (56). Inheritance of the Sry
transgene, even in the presence of XX sex chromosomes, results in development of male
gonads. The FCG model is valuable to identify whether sex differences in a trait of interest
are associated with gonadal type or sex chromosome complement (Figure 4). For example, if
a trait is influenced by gonadal sex, male mice with XX or XY chromosomes will be similar,
but differ from female mice with XX or XY chromosomes. However, if a trait is influenced
by sex chromosome complement, XX female and male mice will be similar to one another,
but differ from XY female and male mice (Figure 4). This model also allows the detection of
interactions between gonadal hormones and chromosomal sex, and the effects of acute
hormones can be assessed by comparing gonadally intact with gonadectomized mice, as
described above. This model has revealed that sex differences in obesity, lipid levels, fatty
liver, glucose homeostasis and other metabolic traits are influenced by XX vs. XY
chromosome complement (Figure 5; described in later sections).

II. Genetic contributions to sex differences in adiposity and obesity
a. Sex-specific obesity loci
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The heritability of obesity is estimated to be about 50–70%, indicating that genetics play a
large role in fat accumulation (reviewed in 38). Recently, large-scale genome-wide
association studies (GWAS) have identified loci linked to fat accumulation and distribution.
A large meta-analysis of 32 GWAS, with a follow-up of 16 loci in 29 additional studies,
identified 14 genome-wide significant loci that were associated with waist-to-hip ratio, a
proxy for adipose distribution (50). In sex-specific meta-analyses, 12 of these 14 singlenucleotide polymorphisms (SNPs) were significant in women, while only three SNPs were
significant in men. The 14 loci collectively explained 1.34% of the waist-to-hip ratio
variance in women and 0.46% of the variance in men. Subsequent studies confirmed these
loci in genome-wide associations with subcutaneous and visceral adipose tissue measured by
CT scan (37, 104). When sex-stratified studies were performed, the reported loci had
statistically significant associations with fat distribution in women, but not in men.
Concordant with these findings, another large meta-analysis of nearly 225,000 individuals
reported 49 loci associated with waist-hip ratio adjusted for body mass index, and 20 of
these 49 loci had significant sexual dimorphism (103). 19 out of 20 sexually dimorphic loci
had a larger effect in women than in men. Taken together, these GWAS findings highlight
the importance of performing sex-stratified GWAS to better understand genetic contributors
of adiposity. These findings also emphasize that a large proportion of the genetic
determinants of obesity in both sexes remain to be identified.
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b. Sex differences in regional adipose tissue deposition
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It is well appreciated that there are inherent differences between men and women in fat
distribution and properties of fat cells within anatomical depots (Figure 1). When
normalized to waist circumference or to total body fat, men have more visceral adipose
tissue (fat within the abdominopelvic cavity) than pre-menopausal women (64, 66). Men
also tend to lose relatively more visceral adipose tissue due to calorie restriction than women
(63). By contrast, women typically have more subcutaneous adipose tissue (fat underlying
the dermis) (66). Numerous epidemiological studies have linked increased visceral fat to
MetSyn, and others have suggested that subcutaneous adipose tissue may even play a
protective role against glucose dysregulation and other components of the MetSyn (38, 71,
96, 108). Thus, in the basal state, the greater subcutaneous to visceral adipose tissue
composition in women may be a beneficial trait relative to MetSyn development.

Author Manuscript

Beyond sex differences in fat mass and distribution, metabolic differences have been
identified in adipocyte biology between men and women that ultimately may contribute to
the likelihood for abdominal obesity that contributes to MetSyn. For example, a comparison
of adipocytes isolated from the subcutaneous and visceral compartments of abdominal fat in
healthy women showed that the intraperitoneal adipocytes were 20–30% smaller than those
from the subcutaneous depot, whereas men exhibit a similar adipocyte size from these two
areas of abdominal fat (106). This is relevant because larger adipocytes have higher rates of
lipolysis, are correlated with insulin resistance, and have increased expression of
proinflammatory adipokines. It is possible that changes in the basal characteristics of
adipocytes in women with abdominal obesity are highly detrimental and contribute to the
development of MetSyn.

Author Manuscript

c. Gonadal hormone signaling effects on adiposity and potential effectors
The mechanisms underlying sex differences in adiposity have been investigated extensively
in experimental models by manipulating receptors for gonadal hormone signaling. In
particular, ablation of estrogen and androgen receptors in the brain and peripheral tissues in
the mouse results in striking metabolic outcomes. For example, knockout of estrogen
receptor α (ERα) resulted in increased adiposity in both male and female mice (51, 87).
Knockout of ERα in hypothalamic neurons also lead to dysregulation of energy balance,
resulting in increased abdominal fat (84, 117). While deficiency of ERα affects both sexes,
deficiency of androgen receptor results in late-onset obesity only in males (36). Interestingly,
adipose-specific knockout of androgen receptor causes hyperleptinemia, but not increased
adiposity. This suggests that androgen receptor is required in adipocytes for normal levels of
leptin, but not for expansion of fat tissue.

Author Manuscript

While gonadal hormones have an irrefutable role in shaping and distributing fat, the specific
mechanisms have not been fully elucidated. One possible mechanism is a role for gonadal
hormones, along with nutrients and other signals, as cues to signal adipocyte progenitor cells
to proliferate and/or differentiate. Indeed, ovarian hormones appear to influence fad pad
expansion in a sex-specific manner (57). In mice fed a high fat diet, adipocyte precursor
cells proliferate and differentiate into mature adipocytes to a much greater degree than in
mice fed a standard chow diet, as would be expected. Interestingly, the removal of acute
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hormonal effects in females by ovariectomy blunts the proliferative capacity of
preadipocytes in the subcutaneous fat pad, but not the visceral fat pad. These results suggest
that gonadal hormones affect precursor cells differentially in distinct fat depots. In addition,
elegant adipose tissue transplant studies revealed that adipocyte precursor cell behavior is
dictated by the recipient depot, implicating environment rather than cell-intrinsic properties
as a determinant of fat tissue hyperplasia (57).

Author Manuscript

Another potential effector of sex hormone effects on adipose tissue depot expansion may be
the enzyme aldehyde dehydrogenase 1 (Aldh1a1) (119). Deletion of Aldh1a1 abrogated dietinduced expansion of subcutaneous fat in male and female mice compared to wild-type
animals. However, compared to the corresponding wild-type mice, visceral fat mass was
reduced in female but not male Aldh1a1−/− mice. The female-specific reduction in visceral
fat of Aldh1a1−/− mice was attributed to differential expression of adipose triglyceride
lipase, which was likely induced by a buildup of retinaldehyde in Aldh1a1−/− females. The
authors postulate that the retinoic acid produced by Aldh1a1 action may activate retinoic
acid receptor response elements (such as in the promoter of the PPARγ gene) to a greater
degree in female compared to male visceral adipose tissue. While this study identified an
interesting potential role of retinoic acid in mediating sex differences in fat depots, more
research is needed to understand how sex-biasing factors, such as sex hormones and sex
chromosomes, interact with retinaldehyde and retinoic acid signaling pathways.
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Sex-biasing factors, such as sex hormones and sex chromosomes, likely mediate sexually
dimorphic traits via changes in gene expression. Thousands of sexually dimorphic genes
have been identified in adipose tissue by global gene expression analysis in mice (45, 118).
These genes were enriched in functional categories such as immune response, lipid
metabolism, and insulin signaling. The mice used in these studies were fed a high fat diet
(45–47% calories from fat) to increase adiposity, such that some of the observed sexually
dimorphic gene expression may reflect sex-dependent responses to nutritional excess and the
ensuing metabolic dysregulation. Interestingly, only about 100 genes were differentially
expressed between ovariectomized females and gonadally intact females, suggesting that
most sexually dimorphic genes are not regulated by circulating gonadal hormones (45).

Author Manuscript

One factor that may contribute to sexually dimorphic gene expression is regulator of sexlimitation 1 (RSL1), a zinc finger protein that affects the expression of many transcripts in
liver and adipose tissue. Deletion of Rsl1 in mice results in sex-specific weight gain (61).
Rsl1−/− females gain significantly more weight compared to wild-type females, while
Rsl1−/− and wild-type males have equal weight gain on a high fat diet. In addition, Rsl
deficiency enhanced sexual dimorphism in adipose tissue gene expression compared to wildtype mice, suggesting that RSL1 normally suppresses sex differences in adipose tissue.
d. Sex chromosome complement influences adiposity
The obesity loci discovered in GWAS studies and the studies from experimental models
discussed above account for a small proportion of the estimated genetic heritability of
obesity. The missing heritability may arise from a number of factors, including a lack of
power to detect combined effects of numerous loci, which individually, may have
insignificant associations with adiposity traits. In addition, few GWAS reports stratify
Annu Rev Nutr. Author manuscript; available in PMC 2018 August 21.
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associations by sex, thus potentially obscuring our understanding of complex diseases. To
determine genetic causes of sex differences in adiposity, one must consider the fundamental
definition of sex in a cell: the sex chromosome complement.
In many cases, the X chromosome is not included in GWAS studies, because arrays do not
have enough X chromosome variants, or because imputation is needed for combined-sex
studies (116). This practice impedes discovery of novel associations, especially with
sexually dimorphic traits such as adiposity. There are more than 1,600 coding and hundreds
of noncoding genes on the X chromosome, which represent greater than 5% of all human
genes. The number of X chromosomes, the ability to randomly inactivate an X chromosome,
and X chromosome imprinting are sources of sex differences between females and males
that reside in each nucleated cell of every tissue.
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Mouse models have been used to demonstrate an effect of XX vs. XY chromosome
complement on fat accumulation and obesity co-morbidities. Chen et al. used the Four Core
Genotypes mouse model (Figure 3) to distinguish effects of sex hormones from effects of
sex chromosomes on obesity (21). All genotypes were on an inbred C57BL/6 background,
ruling out genetic differences besides sex chromosome complement. To remove acute effects
of circulating hormones, mice were gonadectomized in early adulthood. Mice with two X
chromosomes, regardless of whether they originally had ovaries or testes, gained nearly
twice as much fat as mice with X and Y chromosomes (Figure 5). Remarkably, the enhanced
weight gain in XX mice was observed on a standard chow diet. The weight difference
between XX and XY mice was amplified by a high fat diet, becoming statistically significant
after merely 3 days on the diet. The increased obesity in XX mice was associated with
increased food intake during the light (inactive) phase of the circadian cycle (21, 22). Along
with increased adiposity, XX mice developed fatty liver and had elevated levels of fasting
insulin (Figure 5), both of which are co-morbidities of obesity in humans.
The provocative finding that XX mice have greater adiposity than XY mice raised the
question of whether the effect was due to the presence of two X chromosomes, or to the
absence of a Y chromosome. To address this, investigators generated mice with XX, XY, XO
and XXY sex chromosome complements. When body weight of these mice was followed for
several months following gonadectomy, the XX and XXY mice had greater body weight
than XY and XO mice (21). Thus, it was the presence of two X chromosomes that drove
increased body weight, irrespective of inclusion of a Y chromosome. Interestingly, another
mouse model of altered sex chromosome number also showed increased body weight in
mice with two X chromosomes compared to those with one X, regardless of the presence of
a Y chromosome (23).

Author Manuscript

The studies described above implicate X chromosome dosage as a risk factor for obesity. It
will be important to further define the mechanisms involved. One hypothesis is that
increased expression of genes escaping X chromosome inactivation in XX mice may cause
phenotypic differences between XX and XY mice (21, 69, 70). This can be investigated by
modulating the dosage of individual genes that escape X chromosome inactivation in cell or
mouse models to determine effects on downstream gene expression and physiology.
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III. Sex differences in obesity co-morbidities
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In this section, we will review sex differences in co-morbidities of obesity that are also
components of MetSyn. The prevalence of MetSyn varies across world populations, and it is
clear that it is influenced by ethnicity, sex, age and socioeconomic status (47, 97, 98). The
prevalence of MetSyn in the U.S. population is similar in age-adjusted men and women
(34.9% of men, 33.3% of women) (82), but this may differ in other countries (98). The
combination of components that most often lead to a diagnosis of MetSyn differ between the
sexes (97, 98). For example, in women, the predominant component of MetSyn is abdominal
obesity (often measured as waistline circumference), whereas in men, the predominant
component is hypertension (62). In both men and women, these two components occur most
frequently in combination with low HDL cholesterol levels and elevated triglyceride levels
to form the triad of factors used to define MetSyn. Additional components of the MetSyn
and other obesity co-morbidities have also been found to exhibit substantial sex differences
in both humans and mouse models, as reviewed below and summarized in Figure 1.
a. Plasma lipid levels

Author Manuscript

Dyslipidemia is a key component of the MetSyn and often occurs together with obesity. A
widely held generalization regarding lipid levels and cardiovascular disease is that elevated
levels of low density lipoproteins (LDL) are detrimental, whereas elevated high density
lipoproteins (HDL) are beneficial (20). However, the reality is more complex than this.
Recent work indicates that the context in which HDL levels occur (i.e., levels of LDL and
triglycerides) influences the utility of HDL as a predictor of cardiovascular disease risk (9).
Furthermore, specific subspecies of each of the lipoprotein classes appear to be more
relevant to cardiovascular disease prediction than others. In the broadest terms, premenopausal women are found to have higher levels of HDL cholesterol than men, and men
have higher LDL cholesterol levels (11, 39, 43, 58, 75). Within the lipoprotein classes are
subclasses that differ in size, lipid and protein composition, and potentially, function. An
examination of the lipoprotein subclasses reveals that men tend to have a profile that
includes several characteristics associated with cardiovascular disease risk (small LDL,
small HDL, large very low density lipoproteins (VLDL)), whereas women are likely to
likely to have higher concentrations of large HDL particles, which are associated with
athero-protection (58).

Author Manuscript

It is clear that gonadal hormones (either directly or indirectly) influence the lipoprotein
profile. Lipoprotein profiles are altered in women after menopause, and this can be partially
reversed by exogenous hormone replacement therapy (11, 24, 29, 113). Androgen levels in
men also appear to influence lipid levels and cardiovascular disease risk. Conflicting data
exist, but at least some data indicate that androgen action is not likely the major determinant
of LDL cholesterol levels (54, 81, 113, 115). Much work remains to be done to determine
the relevance of specific lipid profile characteristics on cardiovascular disease risk in men
and women. Understanding these mechanisms is important, however, as it will inform
therapeutic approaches and management of cardiovascular disease.
Toward understanding basic mechanisms that influence lipid levels differentially in males
and females, animal models may provide some insight. For example, a study performed in
Annu Rev Nutr. Author manuscript; available in PMC 2018 August 21.
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the Four Core Genotype mouse model identified some aspects of lipid levels that are
determined predominantly by presence of male or female gonads, and other aspects that are
determined by the presence of 2 X chromosomes (as found in XX animals) compared to 1 X
chromosome (as found in XY animals) (70). While humans transport the majority of
cholesterol in the form of LDL particles, mice transport the majority of cholesterol in the
form of HDL particles. However, when fed a cholesterol-enriched diet, mice increase LDL
cholesterol levels substantially to levels resembling humans. Studies of lipid levels in mice
of the Four Core Genotypes (XX female, XX male, XY female, and XY male mice) revealed
that under basal conditions in which the mice were fed a chow diet, plasma HDL cholesterol
levels were higher in animals with XX vs. XY chromosome complement, and also in mice
with male vs. female gonads (Figure 5). LDL cholesterol levels, which were only about onefifth of HDL levels on the chow diet, were similar across the four genotypes, whereas
triglyceride and free fatty acid levels were higher in males compared to females, regardless
of the sex chromosome complement. To determine the contribution of acute-acting gonadal
hormones, adult mice were gonadectomized. This led to a loss of male/female differences,
and accentuated the effects of XX chromosome complement on promoting higher HDL
cholesterol and free fatty acid levels. When fed a cholesterol-enriched diet, LDL cholesterol
levels increased and were similar among the four genotypes. However, XX mice had higher
levels of HDL cholesterol, whereas XY mice had higher levels of triglycerides and free fatty
acids. Importantly, using a separate mouse model with XX, XXY and XY genotypes, it was
demonstrated that HDL cholesterol levels are elevated in XX and XXY mice compared to
XY mice, indicating that the presence of two X chromosomes, rather than absence of a Y
chromosome, confers the high HDL phenotype (70). These results reveal that specific
components of the lipid profile may be influenced independently by gonadal hormones
and/or sex chromosomes, and that the underlying sex chromosome complement, rather than
sex hormones, may be a key determinant of HDL cholesterol levels.
b. Glucose dysregulation
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A common co-morbidity of obesity is impaired glucose homeostasis and insulin resistance.
The standard measures of glucose homeostasis are determinations of fasting glucose levels
or glucose tolerance, the latter measured as the kinetics of glucose clearance from the blood
following an acute glucose load. Abnormal values for either of these traits may indicate
impaired glucose metabolism, but the mechanisms underlying each are distinct. Indeed, only
a minority of individuals with dysregulated glucose metabolism (about one-fourth) exhibit
impairment in both fasting glucose and glucose tolerance (49). Elevated fasting glucose
levels could result from inadequate levels of insulin secretion and/or impaired hepatic insulin
sensitivity, leading to dysregulated glucose production by the liver. By contrast, impaired
glucose tolerance is more likely a result of peripheral insulin resistance at the sites of postprandial glucose disposal, especially skeletal muscle. Notably, men are more likely to
develop elevated fasting glucose levels, whereas women are more likely to develop impaired
glucose tolerance, as shown in a meta-analysis of more than 20 studies from European and
Asian populations (111). Assessments of insulin resistance show greater occurrence in men
than women, even after adjusting for age and body mass index (42, 59, 80, 86). Key
mechanisms that have been implicated include effects of gonadal hormone-dependent and independent sex differences in regional adipose tissue distribution, production of cytokines

Annu Rev Nutr. Author manuscript; available in PMC 2018 August 21.

Link and Reue

Page 10

Author Manuscript

and adipokines, hepatic gluconeogenesis and glycogenolysis, and glucose uptake by skeletal
muscle (1, 86, 102). Sex differences in the mechanisms of dysglycemia raise a concern that
diagnosis of MetSyn based on fasting glucose levels may not reliably identify women that
have MetSyn and should undergo some intervention.
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Sex differences in glucose metabolism have also been described in rodent models. In a
screen of ~100 inbred mouse strains, Park et al. compared males and females for the
development of insulin resistance as assessed by HOMA-IR after feeding a high fat/high
carbohydrate diet (93). In nearly all strains, males were more prone to insulin resistance than
females. HOMA-IR was correlated with total body fat and mesenteric fat pad weights in
both males and females, but only females showed a strong correlation with additional
visceral fat pads (gonadal and retroperitoneal fat depots). A set of three inbred mouse strains
were studied with intact gonads or gonadectomy to determine the impact of gonadal
hormones on the development of diet-induced insulin resistance. Ovariectomy improved
insulin sensitivity in females of all three strains examined, but gonadectomy in male mice
improved insulin sensitivity only in one of the three strains, demonstrating a hormone-gene
interaction (93). Genetic association analyses identified distinct loci in males and females
for plasma insulin and glucose levels (93), underscoring that mechanistic differences exist in
the regulation of glucose metabolism between males and females.
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Another approach to identify mechanisms underlying sex differences in the regulation of
glucose homeostasis is the comparison of sex chromosome and gonadal sex contributions to
glucose metabolism parameters. In most cases in mice and humans, increased adiposity
correlates with insulin resistance. In the Four Core Genotypes mouse model, glucose and
insulin levels were analyzed in mice that were gonadectomized to remove effects of acute
gonadal hormones. As described in an earlier section, XX mice (with either male or female
original gonads) gained more fat than XY mice (of either gonadal type) (21). Despite this,
the XX mice had similar glucose and insulin levels and glucose tolerance as XY mice. The
ability to maintain glucose homeostasis in XX mice despite higher body fat could indicate
that compensatory changes occur in XX mice, as suggested by enhanced fatty acid oxidation
gene expression profiles in muscle and liver (21). When animals are made obese by feeding
a high fat-high carbohydrate diet, the XX mice appear to be more prone to insulin resistance
(Figure 5), as they have two-fold higher plasma insulin levels to maintain similar plasma
glucose levels as XY mice (21). This effect may be secondary to increased obesity in XX
mice.
c. Non-alcoholic fatty liver

Author Manuscript

A common co-morbidity of obesity and insulin resistance is nonalcoholic fatty liver disease
(NAFLD). This condition is characterized by the accumulation of neutral lipids in
hepatocytes and represents the initial stage of a continuum of conditions that can progress to
include severe inflammation (steatohepatitis), and further, to fibrosis and cirrhosis (2, 28).
Data show increased cardiovascular disease mortality and overall mortality in individuals
with NAFLD/steatohepatitis (34, 88), but it is difficult to disentangle this risk from that due
to conditions that typically occur in tandem, such as obesity and MetSyn (120). Sex
differences have been noted in the prevalence of NAFLD, but these vary depending on the
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criteria used to define NAFLD, ethnicity, and other clinical characteristics of the subjects
(91). In population-based studies, which may have less ascertainment bias than case-control
studies, men have been found to have higher incidence of NAFLD than women (reviewed in
68). In some, but not all cases, the greater occurrence of NAFLD in men remained after
adjustment for body weight and insulin resistance (15, 25). Interestingly, in a study where
individuals are segregated into lean and overweight/obese groups, lean women had a higher
incidence of NAFLD than lean men (121). There may be distinct mechanistic etiologies for
fatty liver that occurs in the context of obesity compared to that occurring in lean
individuals.
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As with most metabolic phenotypes discussed here, gonadal hormones likely contribute to
differences in fatty liver development, either directly through estrogen and androgen
receptor signaling, or indirectly through effects on adiposity, insulin resistance, etc. Studies
in male rats that were gonadectomized and treated with estradiol or dihydrotestosterone
showed that both of these hormones decreased lipid accumulation in the liver (124).
Estradiol appeared to reduce fatty acid synthesis, and testosterone increased cholesterol
synthesis, each in specific hepatic zones. Studies using the Four Core Genotypes mouse
model indicate that gonad-independent mechanisms also influence fatty liver development.
Mice that were gonadectomized as adults and then fed a high fat/high carbohydrate diet for
12 weeks gained substantial body weight and fat, regardless of gonadal and chromosomal
sex (21). Interestingly, only XX mice developed pronounced fatty liver with large
triglyceride droplets, whereas XY mice accumulated much less triglyceride and only very
small lipid droplets (Figure 5). The XX vs. XY effect occurred regardless of whether the
original gonads were male or female, and occurred in the absence of gonadal secretions,
indicating that gonad-independent sex differences are involved. However, although both XX
and XY mice were obese, the XX mice had greater adiposity and hyperinsulinemia, making
it difficult to determine whether the fatty liver in XX mice was independent or secondary to
these other metabolic effects.

IV. The gut microbiome and sex differences in metabolic syndrome
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In the past several years, there has been a surge in studies investigating the connection
between the gut microbiome and human health. Perturbations in the microbial community
are related to a wide range of diseases, including bowel disorders, autoimmune diseases, and
metabolic disorders (27). Indeed, a direct effect of gut microbiota on obesity was elegantly
demonstrated by transplanting gut microbiota from lean or obese mice into germ-free mice.
Mice that received microbiota from diet-induced or genetically obese mice gained weight
compared to recipients of microbiota from lean donors (109, 110). These findings suggest
that gut flora have the capacity to dramatically influence host metabolism, including effects
on energy acquisition and storage.
Although the field is still young, studies demonstrate that diet, sex, and genetic background
may each influence the composition of the gut microflora, and that the microbial community
in turn impacts hormone levels, immunity, and metabolic homeostasis in the host. Relevant
to obesity, mice fed a high fat/high sucrose diet for 8 weeks dramatically changed their
microbial makeup compared to chow fed mice, particularly the levels of Bacteroidetes and
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Firmicutes (92). These changes were dependent on the specific mouse strain, indicating that
genetic background influences the gut microbiota composition. Furthermore, some genera
(Akkermansia, Lactococcus, and Allobaculum) were correlated with the gain in body fat due
to diet, highlighting the connection of gut microbes with metabolic health. In addition to
diet, the gut microbiota respond to the diurnal cycle, with fluctuations in major phyla such as
Firmicutes, Bacteroidetes, and Verrucomicrobia (123). Feeding a high fat diet (61% calories
from fat) for 8 weeks suppressed the diurnal fluctuations in microbial composition and
reduced species, which may be detrimental to overall health (72). One hypothesis is that
metabolites produced by the gut flora, including catabolized complex carbohydrates and bile
acids, may signal to and alter host metabolism.
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A recent study investigated the effects of sex on gut microbial communities (89). Of 89
strains of mice examined, 7 strains had significant sex differences in abundance of microbial
taxa. To determine how these sex differences were affected by nutritional excess, the authors
examined male and female C57BL/6J, C3H/HeJ, and DBA/2J mice on a high fat/high
sucrose diet for 8 weeks. They identified a sex-by-diet interaction in microbiota
composition, suggesting that specific taxa respond to diet in a sex-dependent manner. For
example, in DBA/2J mice, members of the Firmicutes phylum increased in females but
decreased in males in response to high fat diet. In addition, gonadectomy revealed that
circulating sex hormones regulate the gut microbiome in a strain- and diet-dependent
manner.
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While many factors influence microbial composition, the gut flora itself remarkably affects
testosterone levels in both males and females (76). Germ-free females had higher levels of
testosterone compared to females housed in specific pathogen-free facilities, while germfree males had reduced levels of testosterone compared to males housed under specific
pathogen-free conditions. Perhaps most strikingly, transplantation of microbiota from adult
male cecum to female weanlings resulted in a significant increase of testosterone at 7 and 14
weeks of age (76). At 34 weeks of age, the microbial community reverted to a population
resembling female gut flora, and testosterone changes were no longer apparent. The
implications of this manipulation were reflected in protection of type 1 diabetes in nonobese
diabetic (NOD) mice. Female mice that had received male cecal bacteria were protected
from autoimmune destruction of pancreatic β cells, while those that had received female
cecal bacteria were not. In addition, treatment of an androgen receptor antagonist abrogated
the protective effects of male cecal bacteria, suggesting that the transfer-mediated enhanced
testosterone levels were required for protection from type 1 diabetes (76). While these and
other data showcase a critical role of the gut microbiome in regulating sex hormones and
diabetes, future studies are needed to fully understand the underlying mechanisms (94).
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Sex differences inherent in the host may also affect processing of metabolites generated by
the gut microbiome. The hepatic enzyme flavin monooxygenase 3 (FMO3) is expressed over
1000 times higher in females compared to males (114). FMO3 catalyzes the last step in the
gut-flora-dependent metabolism of dietary phosphatidylcholine to trimethylamine N-oxide
(TMAO), which is a significant contributor to atherosclerosis (65, 107, 114). Aortic lesion
size was positively correlated with Fmo3 expression levels in Apoe−/− mice (114), and
increased levels of TMAO were associated with thrombosis risk and with a 4-fold increased
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mortality risk (101, 125). As more attention is focused on the impact of TMAO on
cardiovascular disease risk, investigators should keep in mind the innate sex difference in
TMAO levels and Fmo3 expression (105). Taken together, these studies indicate that
complex relationships exist between sex, gut microbiota, and metabolic health, and
underscore the importance of further mechanistic studies.

V. Future Perspectives
a. Increased emphasis on studying sex differences
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Given that sex is one of the most profound biological determinants, it is unfortunate that it
has not always received attention in studies of normo- and pathophysiology. Both preclinical and clinical studies have traditionally focused on a single sex, and more often than
not, this has been male (for examples, see 65, 69, 96). In the case of studies in experimental
animals, a frequent justification was the notion that measurements made in male animals are
less variable due to the hormonal fluctuations that occur during the female reproductive
cycle. These concerns about variation in female rodent models have been refuted by analysis
of published data involving behavior, electrophysiology, neurochemistry, histology and gene
expression (10, 55). In recent years, the need for inclusion of both sexes in pre-clinical
studies has been recognized and publicized (26, 32, 79, 100). It is hoped that these
discussions will lead to a greater transparency in reporting the sexes used in pre-clinical
studies, and increased inclusion of both sexes in both pre-clinical and clinical studies.
b. Tools to investigate sex differences
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To enhance our understanding of sex differences, it is imperative to continue to develop
experimental tools and strategies. As described here, tools such as mouse models that
disentangle the genetic basis of sex determination from the gonadal type are valuable to
begin to interrogate the mechanisms that underlie observed sex differences. Additionally,
genetic manipulation of genes that respond to estrogens and androgens has provided insights
into the many facets of gonadal hormone action in metabolism. In the future, greater
exploitation of this technology to dissect tissue- and temporal-specific effects of estrogen
and androgen signaling would be valuable. A resource to explore sex-specific gene
expression in humans is now available in the form of the Genotype-Tissue Expression
(GTEx) dataset (46). GTEx was developed primarily to identify loci that regulate gene
expression in specific tissues. This has wide applicability in the interpretation of variants
that are identified in GWAS studies and understanding disease mechanisms. GTEx includes
RNA-seq data from approximately 50 human tissues, with hundreds of individual samples
for many of the tissues. Fortunately, the architects of the GTEx project strived to include
tissues from both men and women, such that these data will be useful to compare gene
expression levels and signals for expression quantitative trait loci (eQTL) in men and
women. These data have not yet been tapped extensively to analyze sex differences, but will
undoubtedly be a valuable resource in the future. Along the same lines, it is hoped that more
investigators will include the X chromosome in GWAS analyses, as tools are available for
these analyses and recommendations have been made to promote their use (116).
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VI. Summary
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Despite decades of recognizing sex differences in obesity and cardiovascular disease,
emphasis has seldom been placed on rigorously investigating regulation, interaction, and
effects of sex differences on cellular mechanisms and whole-body physiology. In this review,
we highlighted several key studies that investigate how sex affects obesity and its comorbidities, including insulin resistance, dyslipidemia, and fatty liver. For many years, sex
differences were attributed to gonadal secretions. We and others have begun to reveal the sex
chromosome complement as another determinant of sex differences in health and disease
(Figure 5). However, gonadal hormones and sex chromosome complement are not mutually
exclusive and do not act in isolation. Other factors, including X chromosome imprinting and
inactivation, environmental stimulants, and the gut microbiome may interact with gonadal
hormones and the sex chromosome complement to exert changes in gene expression and
signaling pathways (Figure 6). Diet and circadian rhythms are two of the many external cues
that influence metabolic homeostasis, and have been shown to interact with the gut
microbiome. Although X chromosome imprinting and inactivation and other environmental
factors were beyond the scope of this review, they may have important roles in determining
sex differences in metabolism. There is undoubtedly a complex network that involves many
components of sex differences and metabolism, which will be an exciting area of research in
the future.
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Figure 1. Sex differences in metabolic syndrome (MetSyn) components
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Risk factors for the MetSyn include visceral obesity, elevated triglyceride levels, low high
density lipoprotein levels, hypertension, and elevated fasting glucose levels. Sex differences
occur in most of these traits. Women tend to have increased fat mass proportional to their
body weight, increased subcutaneous adipose tissue, and elevated HDL cholesterol levels.
Men generally have greater proportional lean mass, increased visceral adipose tissue, and
elevated plasma triglyceride levels. Cardiovascular disease incidence also differs by sex,
with women having higher incidence of ischemic stroke, and men higher incidence of
myocardial infarction.

Author Manuscript
Annu Rev Nutr. Author manuscript; available in PMC 2018 August 21.

Link and Reue

Page 22

Author Manuscript
Author Manuscript

Figure 2. Genetic and hormonal components of sex

Male and female sex differences may result from genetic or hormonal components. Normal
females and males differ in their sex chromosome complement of XX or XY, respectively.
They also differ in the presence of ovarian or testicular gonadal hormones. In standard
humans and mouse models, the genetic and gonadal contributions to sex differences cannot
be easily distinguished.

Author Manuscript
Author Manuscript
Annu Rev Nutr. Author manuscript; available in PMC 2018 August 21.

Link and Reue

Page 23

Author Manuscript
Author Manuscript

Figure 3. Distinction of gonadal and chromosomal contributions to sex differences using the Four
Core Genotypes mouse model

The Four Core Genotypes mouse model breaks sex into gonadal type and sex chromosome
complement as independent determinants. The four genotypes can be used to study the
contribution of gonadal and chromosomal sex to traits of interest.
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Figure 4. Using the Four Core Genotypes mouse model to study sex differences

Studies with the Four Core Genotypes are performed in a 2 x 2 comparison, using gonadal
type (ovaries vs. testes) and chromosomal type (XX vs. XY) as the categories. A comparison
of XX vs. XY mice (on both gonadal backgrounds) allows detection of effects due to sex
chromosome complement. A comparison of female vs. male mice (with both sex
chromosome genotypes) allows detection of effects due to gonadal type.
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Figure 5. Sex chromosome complement confers sex differences in MetSyn traits

Studies using the Four Core Genotypes mouse model have revealed that sex differences in
some traits associated with MetSyn are influenced by the sex chromosome complement. For
example, XX mice, regardless of having ovaries or testes, have increased fat mass relative to
body weight, are susceptible to fatty liver, and exhibit increased HDL cholesterol. XY mice
have been shown to have greater inflammation in the central nervous system (33) and
improved cardiac recovery after ischemia injury (67).
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Figure 6. Sex differences in metabolism are influenced by many factors
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Two primary sex-biasing sources are the sex chromosome complement and gonadal
hormones, which in turn are influenced by other factors. The white arrows represent
mediators of regulation, including gene expression changes and altered protein signaling
pathways. In addition to the number of X chromosomes and the presence of a Y
chromosome, XX and XY cells differ by the occurrence of X chromosome inactivation
(exclusively in XX cells) and by the parent-of-origin X chromosome imprinting (only XX
cells have X chromosome imprints from both parents). The gut microbiome and
environmental factors such as diet, pollutants, and circadian cycle may interact with the sex
chromosome complement and gonadal hormones to affect metabolism differently between
males and females.
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